Cigna Corp (CI · NYSE)

CI · MARKET VIEW

Market view · as of Aug 3, 2026

Revenue (TTM)
$282.38B
+6.7% YoY
Gross margin
9.1%
EPS (latest q)
$7.78
vs $7.58 est · beat
52-wk position
59.1%
-8.8% vs 52w high · -3.0% 1mo

Price (last ~year)

Cigna (CI) reported second-quarter 2026 revenue of $71.67 billion, marking a fourth consecutive quarter of earnings beats. Performance within the Evernorth segment showed divergence, as specialty care profits rose 22% while pharmacy benefit earnings fell 27%. The stock currently trades at $279.05, reflecting a P/E ratio of 11.54 and sitting below the average analyst price target of $343.38.

Valuation

Market cap
$73.74B
P/E
11.54
PEG
0.835
P/B
1.73
P/S
0.261
EV/EBITDA
7.7
Beta
0.303
Analyst target
$343.38

Quality & returns

Gross margin
9.1%
Operating margin
4.0%
Profit margin
2.3%
ROE
16.8%
ROA
4.5%

Price movement

Last
$279.05
1-month
-3.0%
3-month
+1.8%
RSI (14)
33
vs SMA200
+0.5%
52-wk position
59.1% -8.8% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$71.67B$2.68B$1.66B$2.61B
2026-03-31$68.49B$2.36B$1.65B$3.28B
2025-12-31$72.47B$2.15B$1.23B$2.54B
2025-09-30$69.75B$2.58B$1.87B$3.34B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots